Biotechnology Stocks II Performance Guide: REGENXBIO Inc. (RGNX)
RGNX has no dividends.
Table and Chart of RGNX Performance
See what a $1,000 investment in RGNX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RGNX Returns | |
|---|---|
| Start Date | Oct-30-2015 |
| Start Price | $15.46 |
| End Date | Jul-26-2024 |
| End Price | $14.33 |
| # Prices | 106 |
| Min Date | Jun-30-2016 |
| Min Price | $8.00 |
| Max Date | Sep-28-2018 |
| Max Price | $75.50 |
| Total Return | -7.31% |
| Annualized Return | -0.86% |
| Current Value of $1,000 Purchase | $927 |
| Number Returns | 5,565 |
| Average Return | 30.73% |
| Number Profitable Returns | 2,516 |
| Percent Profitable Returns | 45.21% |
| Number Unprofitable Returns | 3,049 |
| Percent Unprofitable Returns | 54.79% |
| Profitable to Unprofitable Returns Ratio | 0.83 |
| RGNX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $713,793,000 |
| Beta | 1.264 | Price to Sales | 9.83 |
| Earnings per Share | $-5.8700 |
| PE Ratio | None |
| PE to Growth Ratio | 0.26 |
| Price to Book | 2.848 |
| PRICE DATA | |
| 52 Week High | $28.8 |
| 52 Week Low | $10.49 |
| Analyst Target Price | $38.92 |
| 50-Day Moving Average | $13.28 |
| 200-Day Moving Average | $16.58 |
| FINANCIAL DATA | |
| Revenue per Share | $1.957 |
| Revenue | $86,726,000 |
| Profit Margin | -300% |
| Return on Equity | -60.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RGNX Compare Returns with S&P 500
RGNX Trendline Chart
RGNX Moving Average Chart
RGNX Stock Return Map - See Patterns of Gains and Losses
RGNX Stock Returns/Purchase Dates